Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3
- PMID: 8183550
Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3
Abstract
Ki-1 lymphoma is a subtype of human malignant lymphoma characterized by the expression of CD30 (Ki-1) and a peculiar morphology. It is occasionally accompanied by a unique reciprocal chromosomal translocation t(2;5)(p23;q35). A Ki-1 lymphoma cell line, AMS3, was established by maintaining biopsied tumor cells in SCID (severe combined immunodeficiency) mice. To investigate abnormalities of the signal transduction in Ki-1 lymphomas, AMS3 lysate was immunoprecipitated with anti-phosphotyrosine monoclonal antibody, 25.2G4, and the immunoprecipitates were subjected to kinase assay and immuno-blotting with 25.2G4. A unique phosphotyrosine-containing protein of MW 80,000, designated p80, was found only in AMS3 cells and not in other cell lines or mononuclear cells from healthy donors. Subsequent amino acid sequence analysis of its tryptic digests showed that p80 was a hitherto undescribed tyrosine phosphoprotein similar to Ltk (leukocyte tyrosine kinase). Furthermore, physical interaction of p80 with CD30 was suggested from immunoprecipitation experiments with AMS3 lysates.
Similar articles
-
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.Blood. 1994 Dec 1;84(11):3648-52. Blood. 1994. PMID: 7949120
-
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.Leukemia. 1996 Jan;10(1):142-9. Leukemia. 1996. PMID: 8558920
-
Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.Ann Oncol. 1997;8 Suppl 1:37-42. Ann Oncol. 1997. PMID: 9187427
-
Translocations involving anaplastic lymphoma kinase (ALK).Oncogene. 2001 Sep 10;20(40):5623-37. doi: 10.1038/sj.onc.1204594. Oncogene. 2001. PMID: 11607814 Review.
-
Individualized target therapy of malignant lymphomas: an outlook.Recent Results Cancer Res. 2007;176:177-88. doi: 10.1007/978-3-540-46091-6_15. Recent Results Cancer Res. 2007. PMID: 17607925 Review.
Cited by
-
Possible association between nonsynonymous polymorphisms of the anaplastic lymphoma kinase (ALK) gene and schizophrenia in a Japanese population.J Neural Transm (Vienna). 2006 Oct;113(10):1569-73. doi: 10.1007/s00702-006-0436-3. Epub 2006 Apr 11. J Neural Transm (Vienna). 2006. PMID: 16604305
-
Role and targeting of anaplastic lymphoma kinase in cancer.Mol Cancer. 2018 Feb 19;17(1):30. doi: 10.1186/s12943-018-0776-2. Mol Cancer. 2018. PMID: 29455642 Free PMC article. Review.
-
A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening.Blood. 2019 Jul 11;134(2):171-185. doi: 10.1182/blood.2019001043. Epub 2019 May 31. Blood. 2019. PMID: 31151983 Free PMC article.
-
IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK.Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11977-82. doi: 10.1073/pnas.1100319108. Epub 2011 Jun 29. Proc Natl Acad Sci U S A. 2011. PMID: 21715655 Free PMC article.
-
Treatment for ALK-mutated non-small-cell lung cancer: a new miracle in the research race.Clin Transl Oncol. 2011 Nov;13(11):774-9. doi: 10.1007/s12094-011-0732-8. Clin Transl Oncol. 2011. PMID: 22082640 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials